In this episode, Katja Murray, Senior Director at FTI Consulting, sat down with Thomas Bols, Head of Government Affairs and Patient Engagement, EMEA, to discuss the recently published EU pharmaceutical package and its impact on innovators working in the rare disease space. Check out the episode to learn more about the major changes in the legislation.
Is the EU on your agenda ?